Cell Source, Inc.
CLCS
$0.82
$0.000.00%
OTC PK
| 03/31/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | -21.14% | -22.28% | -22.28% | -13.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -8.19% | -4.90% | -4.90% | -13.94% |
| Operating Income | -- | 8.19% | 4.90% | 4.90% | 13.94% |
| Income Before Tax | -- | 6.73% | 6.71% | 6.71% | 11.89% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | 6.73% | 6.71% | 6.71% | 11.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 6.73% | 6.71% | 6.71% | 11.89% |
| EBIT | -- | 8.19% | 4.90% | 4.90% | 13.94% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | 12.43% | 12.10% | 12.10% | 15.20% |
| Normalized Basic EPS | -- | 18.29% | 17.71% | 17.71% | 20.27% |
| EPS Diluted | -- | 12.43% | 12.10% | 12.10% | 15.20% |
| Normalized Diluted EPS | -- | 18.29% | 17.71% | 17.71% | 20.27% |
| Average Basic Shares Outstanding | -- | 10.09% | 9.41% | 9.41% | 8.86% |
| Average Diluted Shares Outstanding | -- | 10.09% | 9.41% | 9.41% | 8.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |